Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer

连接器 结合 肽 化学 肽库 二肽 寡肽 乳腺癌 抗体-药物偶联物 氨基酸 组织蛋白酶D 生物化学 组织蛋白酶B 组织蛋白酶 蛋白酵素 癌细胞 蛋白酶 癌症免疫疗法 拟肽 癌症研究 分子生物学 肽合成 前药 肽序列 免疫监视 细胞毒性 组织蛋白酶
作者
Oliwia Gorzeń,Maria Łęcka,Natalia Ćwilichowska-Puślecka,Martyna Majchrzak,Natalia Horbach,Jerzy Ł. Wiśniewski,Piotr Jakimowicz,Paweł Szpot,Marcin Zawadzki,Bartosz Dołęga-Kozierowski,Piotr Kasprzak,Boris Turk,Marcin Drąg,Katarzyna M. Groborz,Rafał Matkowski,Marcin Poręba
出处
期刊:Journal of Controlled Release [Elsevier BV]
卷期号:387: 114269-114269 被引量:16
标识
DOI:10.1016/j.jconrel.2025.114269
摘要

Antibody-drug conjugates (ADCs) are a rapidly evolving class of targeted cancer therapeutics that combine the specificity of monoclonal antibodies with the potent cytotoxicity of small-molecule payloads. Their clinical success has led to significant advances in oncology, positioning ADCs as a transformative modality in cancer treatment. Most clinically approved ADCs utilize a protease-cleavable valine-citrulline (Val-Cit) dipeptide linker designed to facilitate intracellular payload release upon proteolytic activation by the lysosomal cathepsins. However, the Val-Cit linker is susceptible to off-target cleavage by proteases expressed in non-malignant tissues, resulting in premature payload release and systemic toxicity. To address this limitation, we established a high-throughput peptide linker discovery platform using Hybrid Combinatorial Substrate Library (HyCoSuL) screening to comprehensively profile protease substrate preferences. By incorporating unnatural amino acids, we identified peptide sequences with high selectivity toward cancer-associated proteases, thereby overcoming the constraints of conventional linker design. As proof of concept, we engineered trastuzumab-based ADCs selectively activated by cathepsin B or cathepsin L and evaluated their cytotoxic efficacy in HER2-positive breast cancer models. Our HyCoSuL-guided linkers display higher selectivity toward cathepsins than Val-Cit and enable faster, protease-dependent activation of peptide prodrugs and ADCs in vitro, while also exhibiting enhanced stability in human plasma to minimize premature payload release. Furthermore, recognizing that efficient protease-activated ADC function requires co-expression of both the target antigen and the activating protease, we performed single-cell mass cytometry analysis of patient-derived breast cancer samples to assess the correlation between HER2 and cathepsin expression. This analysis revealed heterogeneous cathepsin expression, underscoring that pairing the antibody target with the appropriate protease-selective linker might critical for robust, tumor-confined payload release. Our findings highlight the importance of patient stratification based on antigen and protease expression profiles, providing a foundation for developing ADCs with greater protease selectivity and minimized off-target activation. SIGNIFICANCE: This work presents a rational chemistry-driven strategy using unnatural amino acids to engineer peptide linkers with high cysteine cathepsins specificity and enhanced stability in human plasma. By combining comprehensive enzymatic profiling with single-cell CyTOF analysis of patient tumors, we outline a framework for precision-guided ADC design and protease-informed patient stratification in HER2-positive breast cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
chloe完成签到 ,获得积分10
1秒前
Yuan88发布了新的文献求助10
1秒前
2秒前
2秒前
小鱼关注了科研通微信公众号
2秒前
枫叶完成签到,获得积分10
3秒前
西瓜汁发布了新的文献求助10
3秒前
3秒前
李健的应助被Lu采纳,获得10
3秒前
上官若男的应助被科研通管家采纳,获得10
4秒前
drizzle发布了新的文献求助10
4秒前
华仔的应助被科研通管家采纳,获得10
4秒前
科目三的应助被科研通管家采纳,获得10
4秒前
Ava的应助被科研通管家采纳,获得10
4秒前
隐形曼青的应助被科研通管家采纳,获得10
5秒前
5秒前
null的应助被科研通管家采纳,获得10
5秒前
Akim的应助被kaia采纳,获得10
5秒前
打打的应助被科研通管家采纳,获得10
5秒前
Hello的应助被科研通管家采纳,获得10
5秒前
5秒前
无极微光的应助被科研通管家采纳,获得20
5秒前
顾矜的应助被科研通管家采纳,获得10
5秒前
fan的应助被科研通管家采纳,获得20
5秒前
钟小先生完成签到 ,获得积分10
5秒前
汉堡包的应助被科研通管家采纳,获得10
6秒前
DW的应助被科研通管家采纳,获得10
6秒前
王富贵发布了新的文献求助10
6秒前
脑洞疼的应助被科研通管家采纳,获得30
6秒前
完美世界的应助被科研通管家采纳,获得10
6秒前
6秒前
科目三的应助被科研通管家采纳,获得10
6秒前
pluto的应助被科研通管家采纳,获得10
6秒前
6秒前
乐空思的应助被科研通管家采纳,获得100
6秒前
汉堡包的应助被刘刘宇航采纳,获得10
6秒前
无花果的应助被科研通管家采纳,获得10
6秒前
所所的应助被科研通管家采纳,获得10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184220
求助须知:如何正确求助?哪些是违规求助? 9573266
关于积分的说明 21830447
捐赠科研通 7781246
什么是DOI,文献DOI怎么找? 3434248
关于科研通互助平台的介绍 2558373
邀请新用户注册赠送积分活动 2480784